Bethesda, MD – (January 27, 2017) For Immediate Release – Consero Group, an international leader in creating high-level, invitation-only events for senior-level executives, announced today that its 2017 IP Executive Roundtable For Life Sciences will be held on March 30 at Loews Boston Hotel in Boston, Massachusetts. The event will be chaired by John Covert, Director at Sterne, Kessler, Goldstein & Fox.
“The IP management landscape within the life sciences is changing constantly, compelling practitioners in the industry to remain aware of current and looming risks to their company’s IP portfolio,” said Paul Mandell, Founder and CEO of Consero. “Through this one-day, discussion-driven event, we will provide an important opportunity for IP executives in the industry to discuss best practices in an intimate, benchmark-driven setting.”
The roundtable will focus on industry issues including trademark infringement, avoiding IP risk in business transactions, and other emerging trends. Heads of IP from life sciences companies in the Boston area will discuss these topics in an intimate group setting throughout the program. Organizations represented include Novartis, AbbVie, Momenta Pharmaceuticals, and Fresenius.
Additional Topics will include:
Founded in 2010, Consero Group is an international leader in creating function-specific events for senior-level executives in industries that include Legal, Compliance, Brand Protection, Customer Experience, HR and Procurement, among others. Based in Bethesda, Maryland, Consero is best known for transforming the executive experience through intimate, invitation-only programs in a sophisticated learning environment with high-level content. For more information on Consero, please visit www.consero.com.